Center-Authored Papers

Filters: Author is Himmelfarb, Jonathan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Suchy-Dicey AM, Laha T, Hoofnagle A, Newitt R, Sirich TL, Meyer TW, Thummel KE, Yanez DN, Himmelfarb J, Weiss NS et al..  2016.  Tubular Secretion in CKD.. Journal of the American Society of Nephrology : JASN. 27(7):2148-55. Abstract
P
Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Brunelli S, Heagerty PJ, Katz R, Molnar MZ, Nissenson A, Ravel V et al..  2015.  Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. Abstract
N
Ligresti G, Nagao RJ, Xue J, Choi YJ, Xu J, Ren S, Aburatani T, Anderson SK, MacDonald JW, Bammler TK et al..  2016.  A Novel Three-Dimensional Human Peritubular Microvascular System.. Journal of the American Society of Nephrology : JASN. 27(8):2370-81. Abstract
M
Munshi R, Johnson A, Siew ED, Ikizler AT, Ware LB, Wurfel MM, Himmelfarb J, Zager RA.  2011.  MCP-1 gene activation marks acute kidney injury.. Journal of the American Society of Nephrology : JASN. 22(1):165-75. Abstract
I
Kelly EJ, Wang Z, Voellinger JL, Yeung CK, Shen DD, Thummel KE, Zheng Y, Ligresti G, Eaton DL, Muczynski KA et al..  2013.  Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system.. Stem cell research & therapy. 4 Suppl 1:S17. Abstract
H
Marcu R, Choi YJ, Xue J, Fortin CL, Wang Y, Nagao RJ, Xu J, MacDonald JW, Bammler TK, Murry CE et al..  2018.  Human Organ-Specific Endothelial Cell Heterogeneity.. iScience. 4:20-35. Abstract
Johnson ACM, Ware LB, Himmelfarb J, Zager RA.  2011.  HMG-CoA Reductase Activation and Urinary Pellet Cholesterol Elevations in Acute Kidney Injury.. Clinical journal of the American Society of Nephrology : CJASN. 6(9):2108-13. Abstract
E
Rivara MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Katz R, Molnar MZ, Ravel V, Soohoo M et al..  2016.  Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.. Kidney international. Abstract
Yeung CK, Shen DD, Thummel KE, Himmelfarb J.  2014.  Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport.. Kidney international. 85(3):522-8. Abstract
Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, Linke L, Shen DD, Ikizler AT, Himmelfarb J.  2016.  Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.. American journal of kidney diseases : the official journal of the National Kidney Foundation. Abstract
C
Yeung CK, Billings FT, Claessens AJ, Roshanravan B, Linke L, Sundell MB, Ahmad S, Shao B, Shen DD, Ikizler AT et al..  2015.  Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress.. BMC nephrology. 16(1):183. Abstract
A
Robinson-Cohen C, Newitt R, Shen DD, Rettie AE, Kestenbaum BR, Himmelfarb J, Yeung CK.  2016.  Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients.. PloS one. 11(8):e0161074. Abstract
Claessens AJ, Yeung CK, Risler LJ, Phillips BP, Himmelfarb J, Shen DD.  2015.  ANNALS EXPRESS: Rapid and sensitive analysis of reduced and oxidized coenzyme Q10 in human plasma by UPLC-MS/MS and application to studies in healthy human subjects.. Annals of clinical biochemistry. Abstract